Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Updated prezzie

<< Previous

Bullboard Posts

Next >>

Comment by BlueJays9293on May 21, 2024 3:26pm

123 Views

Post# 36050591

RE:RE:RE:RE:Updated prezzie

Considering PMX/EAA is the only significant thing in Vantive's pipeline, I'd say they've done a very indepth analysis on the 50% rights they own, AND the much juicier 50% that they don't own. As well as an analysis on how approval of PMX will significantly drive adoption of the only machine (Prismax) that will be FDA cleared to use our filter.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages